Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826806) titled 'Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Laparoscopic Hepatectomy' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
Condition:
Pain Management
Intervention:
Drug: Anrikefon Injection
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 2026
Target Sample Size: 108
To know more, visit https://clinicaltrials.gov...